カテゴリ： 世界, 部品/材料, QYResearch

ナノ粒子媒介送達の世界市場2023年：生物由来、非生物由来

■ 英語タイトル：Global Nanoparticle-Mediated Delivery Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7509）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7509
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ナノ粒子媒介送達の世界市場2023年：生物由来、非生物由来]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はナノ粒子媒介送達のグローバル市場について調査・分析し、世界のナノ粒子媒介送達市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（生物由来、非生物由来）、用途別セグメント分析（ドラッグデリバリー、遺伝子デリバリー）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、AbbVie、BlueWillow Biologics、NovaSOL、Camurus、Ceramisphere、Celgene, CytImmune、Cristal Therapeutics、EnColl、Lena Nanoceutics Ltd.、EyePoint Pharmaceuticals、Nanobiotix、NanoCarrier、Nanospectra、NanOlogy、Selecta Biosciences、Parvus Therapeutics、Starpharma、Tarveda Therapeuticsなどが含まれています。ナノ粒子媒介送達のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ナノ粒子媒介送達市場規模を算出する際に考慮しました。

・ナノ粒子媒介送達市場の概要
- ナノ粒子媒介送達の種類別セグメント
- 世界のナノ粒子媒介送達市場規模：タイプ別分析（生物由来、非生物由来）
- ナノ粒子媒介送達の用途別セグメント
- 世界のナノ粒子媒介送達市場規模：用途別分析（ドラッグデリバリー、遺伝子デリバリー）
- 世界のナノ粒子媒介送達市場規模予測（2018年-2029年）

・ナノ粒子媒介送達市場の成長トレンド
- ナノ粒子媒介送達の地域別市場規模（2018年-2029年）
- ナノ粒子媒介送達市場ダイナミクス
- ナノ粒子媒介送達の業界動向
- ナノ粒子媒介送達市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：生物由来、非生物由来
- 世界のナノ粒子媒介送達のタイプ別市場規模（2018年-2023年）
- 世界のナノ粒子媒介送達のタイプ別市場規模（2024年-2029年）

・用途別セグメント：ドラッグデリバリー、遺伝子デリバリー
- 世界のナノ粒子媒介送達の用途別市場規模（2018年-2023年）
- 世界のナノ粒子媒介送達の用途別市場規模（2024年-2029年）

・ナノ粒子媒介送達の地域別市場規模
- 北米のナノ粒子媒介送達市場規模（2018年-2029年）
- 米国のナノ粒子媒介送達市場規模（2018年-2029年）
- ヨーロッパのナノ粒子媒介送達市場規模（2018年-2029年）
- アジア太平洋のナノ粒子媒介送達市場規模（2018年-2029年）
- 中国のナノ粒子媒介送達市場規模（2018年-2029年）
- 日本のナノ粒子媒介送達市場規模（2018年-2029年）
- 韓国のナノ粒子媒介送達市場規模（2018年-2029年）
- インドのナノ粒子媒介送達市場規模（2018年-2029年）
- オーストラリアのナノ粒子媒介送達市場規模（2018年-2029年）
- 中南米のナノ粒子媒介送達市場規模（2018年-2029年）
- 中東・アフリカのナノ粒子媒介送達市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
AbbVie、BlueWillow Biologics、NovaSOL、Camurus、Ceramisphere、Celgene, CytImmune、Cristal Therapeutics、EnColl、Lena Nanoceutics Ltd.、EyePoint Pharmaceuticals、Nanobiotix、NanoCarrier、Nanospectra、NanOlogy、Selecta Biosciences、Parvus Therapeutics、Starpharma、Tarveda Therapeutics

・アナリストの観点/結論

・調査手法と情報源

Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
In this report, we only study liposomal/lipid nanoparticle drug delivery system.

LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).
In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
Highlights
The global Nanoparticle-Mediated Delivery market was valued at US$ 4766.2 million in 2022 and is anticipated to reach US$ 5927.2 million by 2029, witnessing a CAGR of 3.7% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.
Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent.
In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nanoparticle-Mediated Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanoparticle-Mediated Delivery.
The Nanoparticle-Mediated Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nanoparticle-Mediated Delivery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanoparticle-Mediated Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AbbVie
BlueWillow Biologics
NovaSOL
Camurus
Ceramisphere
Celgene, CytImmune
Cristal Therapeutics
EnColl
Lena Nanoceutics Ltd.
EyePoint Pharmaceuticals
Nanobiotix
NanoCarrier
Nanospectra
NanOlogy
Selecta Biosciences
Parvus Therapeutics
Starpharma
Tarveda Therapeutics
Segment by Type
Biological Origin
Non-Biological Origin
Segment by Application
Drug Delivery
Gene Delivery
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanoparticle-Mediated Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanoparticle-Mediated Delivery Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Biological Origin
1.2.3 Non-Biological Origin
1.3 Market by Application
1.3.1 Global Nanoparticle-Mediated Delivery Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Delivery
1.3.3 Gene Delivery
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanoparticle-Mediated Delivery Market Perspective (2018-2029)
2.2 Nanoparticle-Mediated Delivery Growth Trends by Region
2.2.1 Global Nanoparticle-Mediated Delivery Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nanoparticle-Mediated Delivery Historic Market Size by Region (2018-2023)
2.2.3 Nanoparticle-Mediated Delivery Forecasted Market Size by Region (2024-2029)
2.3 Nanoparticle-Mediated Delivery Market Dynamics
2.3.1 Nanoparticle-Mediated Delivery Industry Trends
2.3.2 Nanoparticle-Mediated Delivery Market Drivers
2.3.3 Nanoparticle-Mediated Delivery Market Challenges
2.3.4 Nanoparticle-Mediated Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanoparticle-Mediated Delivery Players by Revenue
3.1.1 Global Top Nanoparticle-Mediated Delivery Players by Revenue (2018-2023)
3.1.2 Global Nanoparticle-Mediated Delivery Revenue Market Share by Players (2018-2023)
3.2 Global Nanoparticle-Mediated Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanoparticle-Mediated Delivery Revenue
3.4 Global Nanoparticle-Mediated Delivery Market Concentration Ratio
3.4.1 Global Nanoparticle-Mediated Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanoparticle-Mediated Delivery Revenue in 2022
3.5 Nanoparticle-Mediated Delivery Key Players Head office and Area Served
3.6 Key Players Nanoparticle-Mediated Delivery Product Solution and Service
3.7 Date of Enter into Nanoparticle-Mediated Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanoparticle-Mediated Delivery Breakdown Data by Type
4.1 Global Nanoparticle-Mediated Delivery Historic Market Size by Type (2018-2023)
4.2 Global Nanoparticle-Mediated Delivery Forecasted Market Size by Type (2024-2029)
5 Nanoparticle-Mediated Delivery Breakdown Data by Application
5.1 Global Nanoparticle-Mediated Delivery Historic Market Size by Application (2018-2023)
5.2 Global Nanoparticle-Mediated Delivery Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nanoparticle-Mediated Delivery Market Size (2018-2029)
6.2 North America Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nanoparticle-Mediated Delivery Market Size by Country (2018-2023)
6.4 North America Nanoparticle-Mediated Delivery Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanoparticle-Mediated Delivery Market Size (2018-2029)
7.2 Europe Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nanoparticle-Mediated Delivery Market Size by Country (2018-2023)
7.4 Europe Nanoparticle-Mediated Delivery Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanoparticle-Mediated Delivery Market Size (2018-2029)
8.2 Asia-Pacific Nanoparticle-Mediated Delivery Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2018-2023)
8.4 Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanoparticle-Mediated Delivery Market Size (2018-2029)
9.2 Latin America Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nanoparticle-Mediated Delivery Market Size by Country (2018-2023)
9.4 Latin America Nanoparticle-Mediated Delivery Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanoparticle-Mediated Delivery Market Size (2018-2029)
10.2 Middle East & Africa Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2018-2023)
10.4 Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Nanoparticle-Mediated Delivery Introduction
11.1.4 AbbVie Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 BlueWillow Biologics
11.2.1 BlueWillow Biologics Company Detail
11.2.2 BlueWillow Biologics Business Overview
11.2.3 BlueWillow Biologics Nanoparticle-Mediated Delivery Introduction
11.2.4 BlueWillow Biologics Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.2.5 BlueWillow Biologics Recent Development
11.3 NovaSOL
11.3.1 NovaSOL Company Detail
11.3.2 NovaSOL Business Overview
11.3.3 NovaSOL Nanoparticle-Mediated Delivery Introduction
11.3.4 NovaSOL Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.3.5 NovaSOL Recent Development
11.4 Camurus
11.4.1 Camurus Company Detail
11.4.2 Camurus Business Overview
11.4.3 Camurus Nanoparticle-Mediated Delivery Introduction
11.4.4 Camurus Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.4.5 Camurus Recent Development
11.5 Ceramisphere
11.5.1 Ceramisphere Company Detail
11.5.2 Ceramisphere Business Overview
11.5.3 Ceramisphere Nanoparticle-Mediated Delivery Introduction
11.5.4 Ceramisphere Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.5.5 Ceramisphere Recent Development
11.6 Celgene, CytImmune
11.6.1 Celgene, CytImmune Company Detail
11.6.2 Celgene, CytImmune Business Overview
11.6.3 Celgene, CytImmune Nanoparticle-Mediated Delivery Introduction
11.6.4 Celgene, CytImmune Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.6.5 Celgene, CytImmune Recent Development
11.7 Cristal Therapeutics
11.7.1 Cristal Therapeutics Company Detail
11.7.2 Cristal Therapeutics Business Overview
11.7.3 Cristal Therapeutics Nanoparticle-Mediated Delivery Introduction
11.7.4 Cristal Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.7.5 Cristal Therapeutics Recent Development
11.8 EnColl
11.8.1 EnColl Company Detail
11.8.2 EnColl Business Overview
11.8.3 EnColl Nanoparticle-Mediated Delivery Introduction
11.8.4 EnColl Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.8.5 EnColl Recent Development
11.9 Lena Nanoceutics Ltd.
11.9.1 Lena Nanoceutics Ltd. Company Detail
11.9.2 Lena Nanoceutics Ltd. Business Overview
11.9.3 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Introduction
11.9.4 Lena Nanoceutics Ltd. Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.9.5 Lena Nanoceutics Ltd. Recent Development
11.10 EyePoint Pharmaceuticals
11.10.1 EyePoint Pharmaceuticals Company Detail
11.10.2 EyePoint Pharmaceuticals Business Overview
11.10.3 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Introduction
11.10.4 EyePoint Pharmaceuticals Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.10.5 EyePoint Pharmaceuticals Recent Development
11.11 Nanobiotix
11.11.1 Nanobiotix Company Detail
11.11.2 Nanobiotix Business Overview
11.11.3 Nanobiotix Nanoparticle-Mediated Delivery Introduction
11.11.4 Nanobiotix Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.11.5 Nanobiotix Recent Development
11.12 NanoCarrier
11.12.1 NanoCarrier Company Detail
11.12.2 NanoCarrier Business Overview
11.12.3 NanoCarrier Nanoparticle-Mediated Delivery Introduction
11.12.4 NanoCarrier Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.12.5 NanoCarrier Recent Development
11.13 Nanospectra
11.13.1 Nanospectra Company Detail
11.13.2 Nanospectra Business Overview
11.13.3 Nanospectra Nanoparticle-Mediated Delivery Introduction
11.13.4 Nanospectra Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.13.5 Nanospectra Recent Development
11.14 NanOlogy
11.14.1 NanOlogy Company Detail
11.14.2 NanOlogy Business Overview
11.14.3 NanOlogy Nanoparticle-Mediated Delivery Introduction
11.14.4 NanOlogy Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.14.5 NanOlogy Recent Development
11.15 Selecta Biosciences
11.15.1 Selecta Biosciences Company Detail
11.15.2 Selecta Biosciences Business Overview
11.15.3 Selecta Biosciences Nanoparticle-Mediated Delivery Introduction
11.15.4 Selecta Biosciences Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.15.5 Selecta Biosciences Recent Development
11.16 Parvus Therapeutics
11.16.1 Parvus Therapeutics Company Detail
11.16.2 Parvus Therapeutics Business Overview
11.16.3 Parvus Therapeutics Nanoparticle-Mediated Delivery Introduction
11.16.4 Parvus Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.16.5 Parvus Therapeutics Recent Development
11.17 Starpharma
11.17.1 Starpharma Company Detail
11.17.2 Starpharma Business Overview
11.17.3 Starpharma Nanoparticle-Mediated Delivery Introduction
11.17.4 Starpharma Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.17.5 Starpharma Recent Development
11.18 Tarveda Therapeutics
11.18.1 Tarveda Therapeutics Company Detail
11.18.2 Tarveda Therapeutics Business Overview
11.18.3 Tarveda Therapeutics Nanoparticle-Mediated Delivery Introduction
11.18.4 Tarveda Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2018-2023)
11.18.5 Tarveda Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nanoparticle-Mediated Delivery Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Biological Origin
Table 3. Key Players of Non-Biological Origin
Table 4. Global Nanoparticle-Mediated Delivery Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Nanoparticle-Mediated Delivery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Nanoparticle-Mediated Delivery Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Nanoparticle-Mediated Delivery Market Share by Region (2018-2023)
Table 8. Global Nanoparticle-Mediated Delivery Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Nanoparticle-Mediated Delivery Market Share by Region (2024-2029)
Table 10. Nanoparticle-Mediated Delivery Market Trends
Table 11. Nanoparticle-Mediated Delivery Market Drivers
Table 12. Nanoparticle-Mediated Delivery Market Challenges
Table 13. Nanoparticle-Mediated Delivery Market Restraints
Table 14. Global Nanoparticle-Mediated Delivery Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Nanoparticle-Mediated Delivery Market Share by Players (2018-2023)
Table 16. Global Top Nanoparticle-Mediated Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticle-Mediated Delivery as of 2022)
Table 17. Ranking of Global Top Nanoparticle-Mediated Delivery Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Nanoparticle-Mediated Delivery Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Nanoparticle-Mediated Delivery Product Solution and Service
Table 21. Date of Enter into Nanoparticle-Mediated Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nanoparticle-Mediated Delivery Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Nanoparticle-Mediated Delivery Revenue Market Share by Type (2018-2023)
Table 25. Global Nanoparticle-Mediated Delivery Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Nanoparticle-Mediated Delivery Revenue Market Share by Type (2024-2029)
Table 27. Global Nanoparticle-Mediated Delivery Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Nanoparticle-Mediated Delivery Revenue Market Share by Application (2018-2023)
Table 29. Global Nanoparticle-Mediated Delivery Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Nanoparticle-Mediated Delivery Revenue Market Share by Application (2024-2029)
Table 31. North America Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Nanoparticle-Mediated Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Nanoparticle-Mediated Delivery Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Nanoparticle-Mediated Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Nanoparticle-Mediated Delivery Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Nanoparticle-Mediated Delivery Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Nanoparticle-Mediated Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Nanoparticle-Mediated Delivery Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2024-2029) & (US$ Million)
Table 46. AbbVie Company Detail
Table 47. AbbVie Business Overview
Table 48. AbbVie Nanoparticle-Mediated Delivery Product
Table 49. AbbVie Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. BlueWillow Biologics Company Detail
Table 52. BlueWillow Biologics Business Overview
Table 53. BlueWillow Biologics Nanoparticle-Mediated Delivery Product
Table 54. BlueWillow Biologics Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 55. BlueWillow Biologics Recent Development
Table 56. NovaSOL Company Detail
Table 57. NovaSOL Business Overview
Table 58. NovaSOL Nanoparticle-Mediated Delivery Product
Table 59. NovaSOL Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 60. NovaSOL Recent Development
Table 61. Camurus Company Detail
Table 62. Camurus Business Overview
Table 63. Camurus Nanoparticle-Mediated Delivery Product
Table 64. Camurus Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 65. Camurus Recent Development
Table 66. Ceramisphere Company Detail
Table 67. Ceramisphere Business Overview
Table 68. Ceramisphere Nanoparticle-Mediated Delivery Product
Table 69. Ceramisphere Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 70. Ceramisphere Recent Development
Table 71. Celgene, CytImmune Company Detail
Table 72. Celgene, CytImmune Business Overview
Table 73. Celgene, CytImmune Nanoparticle-Mediated Delivery Product
Table 74. Celgene, CytImmune Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 75. Celgene, CytImmune Recent Development
Table 76. Cristal Therapeutics Company Detail
Table 77. Cristal Therapeutics Business Overview
Table 78. Cristal Therapeutics Nanoparticle-Mediated Delivery Product
Table 79. Cristal Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 80. Cristal Therapeutics Recent Development
Table 81. EnColl Company Detail
Table 82. EnColl Business Overview
Table 83. EnColl Nanoparticle-Mediated Delivery Product
Table 84. EnColl Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 85. EnColl Recent Development
Table 86. Lena Nanoceutics Ltd. Company Detail
Table 87. Lena Nanoceutics Ltd. Business Overview
Table 88. Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product
Table 89. Lena Nanoceutics Ltd. Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 90. Lena Nanoceutics Ltd. Recent Development
Table 91. EyePoint Pharmaceuticals Company Detail
Table 92. EyePoint Pharmaceuticals Business Overview
Table 93. EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product
Table 94. EyePoint Pharmaceuticals Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 95. EyePoint Pharmaceuticals Recent Development
Table 96. Nanobiotix Company Detail
Table 97. Nanobiotix Business Overview
Table 98. Nanobiotix Nanoparticle-Mediated Delivery Product
Table 99. Nanobiotix Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 100. Nanobiotix Recent Development
Table 101. NanoCarrier Company Detail
Table 102. NanoCarrier Business Overview
Table 103. NanoCarrier Nanoparticle-Mediated Delivery Product
Table 104. NanoCarrier Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 105. NanoCarrier Recent Development
Table 106. Nanospectra Company Detail
Table 107. Nanospectra Business Overview
Table 108. Nanospectra Nanoparticle-Mediated Delivery Product
Table 109. Nanospectra Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 110. Nanospectra Recent Development
Table 111. NanOlogy Company Detail
Table 112. NanOlogy Business Overview
Table 113. NanOlogy Nanoparticle-Mediated Delivery Product
Table 114. NanOlogy Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 115. NanOlogy Recent Development
Table 116. Selecta Biosciences Company Detail
Table 117. Selecta Biosciences Business Overview
Table 118. Selecta Biosciences Nanoparticle-Mediated Delivery Product
Table 119. Selecta Biosciences Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 120. Selecta Biosciences Recent Development
Table 121. Parvus Therapeutics Company Detail
Table 122. Parvus Therapeutics Business Overview
Table 123. Parvus Therapeutics Nanoparticle-Mediated Delivery Product
Table 124. Parvus Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 125. Parvus Therapeutics Recent Development
Table 126. Starpharma Company Detail
Table 127. Starpharma Business Overview
Table 128. Starpharma Nanoparticle-Mediated Delivery Product
Table 129. Starpharma Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 130. Starpharma Recent Development
Table 131. Tarveda Therapeutics Company Detail
Table 132. Tarveda Therapeutics Business Overview
Table 133. Tarveda Therapeutics Nanoparticle-Mediated Delivery Product
Table 134. Tarveda Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2018-2023) & (US$ Million)
Table 135. Tarveda Therapeutics Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanoparticle-Mediated Delivery Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Nanoparticle-Mediated Delivery Market Share by Type: 2022 VS 2029
Figure 3. Biological Origin Features
Figure 4. Non-Biological Origin Features
Figure 5. Global Nanoparticle-Mediated Delivery Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Nanoparticle-Mediated Delivery Market Share by Application: 2022 VS 2029
Figure 7. Drug Delivery Case Studies
Figure 8. Gene Delivery Case Studies
Figure 9. Nanoparticle-Mediated Delivery Report Years Considered
Figure 10. Global Nanoparticle-Mediated Delivery Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Nanoparticle-Mediated Delivery Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Nanoparticle-Mediated Delivery Market Share by Region: 2022 VS 2029
Figure 13. Global Nanoparticle-Mediated Delivery Market Share by Players in 2022
Figure 14. Global Top Nanoparticle-Mediated Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticle-Mediated Delivery as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Nanoparticle-Mediated Delivery Revenue in 2022
Figure 16. North America Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Nanoparticle-Mediated Delivery Market Share by Country (2018-2029)
Figure 18. United States Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Nanoparticle-Mediated Delivery Market Share by Country (2018-2029)
Figure 22. Germany Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Nanoparticle-Mediated Delivery Market Share by Region (2018-2029)
Figure 30. China Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Nanoparticle-Mediated Delivery Market Share by Country (2018-2029)
Figure 38. Mexico Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Nanoparticle-Mediated Delivery Market Share by Country (2018-2029)
Figure 42. Turkey Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Nanoparticle-Mediated Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. AbbVie Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 45. BlueWillow Biologics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 46. NovaSOL Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 47. Camurus Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 48. Ceramisphere Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 49. Celgene, CytImmune Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 50. Cristal Therapeutics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 51. EnColl Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 52. Lena Nanoceutics Ltd. Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 53. EyePoint Pharmaceuticals Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 54. Nanobiotix Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 55. NanoCarrier Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 56. Nanospectra Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 57. NanOlogy Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 58. Selecta Biosciences Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 59. Parvus Therapeutics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 60. Starpharma Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 61. Tarveda Therapeutics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 無鉱物油インクのグローバル市場展望 2023年-2029年：植物由来、生物由来、その他
  • マイクロニードル媒介薬物送達パッチのグローバル市場展望 2023年-2029年：中空マイクロニードル技術、中実マイクロニードル技術、溶解マイクロニードル技術
  • VTOL/ドローン配送の世界市場2023年：55lbs以下、55lbs以上
  • パーソナルケア用デリバリーシステムの世界市場2023年：リポソーム、マイクロカプセル化、その他
  • ボトルウォーター配達サービスの世界市場2023年：5L、3L、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7509 )"ナノ粒子媒介送達の世界市場2023年：生物由来、非生物由来" (英文：Global Nanoparticle-Mediated Delivery Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。